Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
© 2023. The Author(s)..
The advent of iPSCs has brought about a significant transformation in stem cell research, opening up promising avenues for advancing cancer treatment. The formation of cancer is a multifaceted process influenced by genetic, epigenetic, and environmental factors. iPSCs offer a distinctive platform for investigating the origin of cancer, paving the way for novel approaches to cancer treatment, drug testing, and tailored medical interventions. This review article will provide an overview of the science behind iPSCs, the current limitations and challenges in iPSC-based cancer therapy, the ethical and social implications, and the comparative analysis with other stem cell types for cancer treatment. The article will also discuss the applications of iPSCs in tumorigenesis, the future of iPSCs in tumorigenesis research, and highlight successful case studies utilizing iPSCs in tumorigenesis research. The conclusion will summarize the advancements made in iPSC-based tumorigenesis research and the importance of continued investment in iPSC research to unlock the full potential of these cells.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Molecular cancer - 22(2023), 1 vom: 28. Nov., Seite 189 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chehelgerdi, Matin [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Immunotherapies |
|---|
| Anmerkungen: |
Date Completed 30.11.2023 Date Revised 28.02.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1186/s12943-023-01873-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365086134 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365086134 | ||
| 003 | DE-627 | ||
| 005 | 20240229234519.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12943-023-01873-0 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1311.xml |
| 035 | |a (DE-627)NLM365086134 | ||
| 035 | |a (NLM)38017433 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chehelgerdi, Matin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.11.2023 | ||
| 500 | |a Date Revised 28.02.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a The advent of iPSCs has brought about a significant transformation in stem cell research, opening up promising avenues for advancing cancer treatment. The formation of cancer is a multifaceted process influenced by genetic, epigenetic, and environmental factors. iPSCs offer a distinctive platform for investigating the origin of cancer, paving the way for novel approaches to cancer treatment, drug testing, and tailored medical interventions. This review article will provide an overview of the science behind iPSCs, the current limitations and challenges in iPSC-based cancer therapy, the ethical and social implications, and the comparative analysis with other stem cell types for cancer treatment. The article will also discuss the applications of iPSCs in tumorigenesis, the future of iPSCs in tumorigenesis research, and highlight successful case studies utilizing iPSCs in tumorigenesis research. The conclusion will summarize the advancements made in iPSC-based tumorigenesis research and the importance of continued investment in iPSC research to unlock the full potential of these cells | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Immunotherapies | |
| 650 | 4 | |a Induced pluripotent stem cells | |
| 650 | 4 | |a Personalized medicine | |
| 650 | 4 | |a Regenerative medicine | |
| 650 | 4 | |a Therapy | |
| 650 | 4 | |a Tumorigenesis | |
| 700 | 1 | |a Behdarvand Dehkordi, Fereshteh |e verfasserin |4 aut | |
| 700 | 1 | |a Chehelgerdi, Mohammad |e verfasserin |4 aut | |
| 700 | 1 | |a Kabiri, Hamidreza |e verfasserin |4 aut | |
| 700 | 1 | |a Salehian-Dehkordi, Hosein |e verfasserin |4 aut | |
| 700 | 1 | |a Abdolvand, Mohammad |e verfasserin |4 aut | |
| 700 | 1 | |a Salmanizadeh, Sharareh |e verfasserin |4 aut | |
| 700 | 1 | |a Rashidi, Mohsen |e verfasserin |4 aut | |
| 700 | 1 | |a Niazmand, Anoosha |e verfasserin |4 aut | |
| 700 | 1 | |a Ahmadi, Saba |e verfasserin |4 aut | |
| 700 | 1 | |a Feizbakhshan, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Kabiri, Saber |e verfasserin |4 aut | |
| 700 | 1 | |a Vatandoost, Nasimeh |e verfasserin |4 aut | |
| 700 | 1 | |a Ranjbarnejad, Tayebeh |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular cancer |d 2002 |g 22(2023), 1 vom: 28. Nov., Seite 189 |w (DE-627)NLM120915979 |x 1476-4598 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2023 |g number:1 |g day:28 |g month:11 |g pages:189 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12943-023-01873-0 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2023 |e 1 |b 28 |c 11 |h 189 | ||